Chief Executive Officer
Roger has been a member of the board since he established the company in 2009. Hofseth has a broad and extensive operational and management experience in the seafood industry. He stepped in as CEO August 2017, and is currently also CEO in Hofseth International AS and Hofseth Aqua AS.
Chief Financial Officer
Jon Olav has been with Hofseth BioCare since 2013. Before HBC, he held several management and director positions in corporate banking. Furthermore, Ødegård has worked as a management advisor in several industries, specialized in process and efficiency improvement. He is CEO of HBC Berkåk, Chairman of Nøre Nutrition, Chairman of Hofseth BioCare Rørvik, CEO and Chairman of Brilliant Invest, Chairman of Hofseth BioCare Americas, Inc. and Board Member of Atlantic Delights, HK.
Chief Operating Officer
Karl has been with Hofseth BioCare since 2018. Before HBC, he held several positions in Firmenich, both as Production Manager and General Manager focusing on R&D, innovation, sales and business development, and became Global Innovation and Business Development Director in the Firmenich group.
Chief Scientific Officer
Dr. Framroze has been with the company since it was established in 2009. Bomi is a discovery scientist with over 60 wordwide patents and publications. He has been an Associate Director of Chemical Discovery at American Cyanamid, Executive Director at Gharda Chemicals Ltd. and was Founder/CSO of Row2Technologies Inc. Since 2004 he has been carrying out Discovery research in process technologies, biochemistry, and marine ingredients. He has recently been appointed as a Visiting Scholar at Stanford University School of Medicine.
Chief Commercial Officer
James started his career in London at Goldman Sachs International in 2001 after graduating from the University of Cambridge. He has since enjoyed a successful career at JP Morgan and then as a fund manager of European large-cap equities for 12 years at GLG/MAN Investments PLC and at Millennium Capital Management LLC. He is based in Zurich, Switzerland.
Medical R&D & Investor Relations
Crawford trained in Medicine at the Royal London Hospital and subsequently trained in surgery attaining Fellowship of the Royal College of Surgeons, London, before moving into the commercial world. He worked for 4 years at AstraZeneca in late stage R&D / early commercialisation of oncology pipeline projects and then moved into finance for 15 years. His financial roles were focussed on global healthcare both as an analyst and then as a fund manager. He is based in London, UK.
Head of Commercial Excellence
Kai Morten has been with the company since 2014 and has extensive experience from customer care, sales, quality management and marketing within the telecom and banking industry and has previously worked for Hello, Skandiabanken and NextGenTel. He is also CEO of Nøre Nutrition.
Chief Quality Officer
Angelika has been with Hofseth BioCare since 2016 and has extensive experience from research, product development and quality management from the food industry. She started as researcher at Norwegian University of Life Science, and has later worked for Arcus, Stabburet in Orkla Group and Pharma Marine.